Healthcare & Insurance
Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
Canadian government commits to purchase 52 million doses with option for additional 24 million of Novavax candidate vaccine, NVX-CoV2373GAITHERSBURG, Md., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for
Friday, January 22, 2021
Christina Lake Cannabis Announces 2021 Expansion and Crop Allocation for Upcoming Growing Season
VANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that its executive management and its team of Master Growers have agreed upon a
Friday, January 22, 2021
Brown & Brown, Inc. Announces Quarterly Cash Dividend
DAYTONA BEACH, Fla., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) today announced that the Board of Directors has declared a regular quarterly cash dividend of $0.0925 per share. The dividend is payable on February 17, 2021 to shareholders of record on February 5, 2021.
Friday, January 22, 2021
Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management
GAITHERSBURG, Md., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Madelyn ‘Lyn’ Caltabiano, Ph.D. to the position of Senior Vice
Friday, January 22, 2021
HCI Group Agrees to Acquire Insurance Business in Four Northeast States from United Insurance Holdings Corp.
TAMPA, Fla., Jan. 22, 2021 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE: HCI), an InsurTech company with operations in insurance, software development and real estate, has entered into a renewal rights agreement, dated January 18, 2021, with United Insurance Holding Corp. (NASDAQ: UIHC) pursuant to
Friday, January 22, 2021
Jushi Holdings Inc.’s BEYOND / HELLO to Open Its 14th Dispensary Nationally and Fourth in Illinois: BEYOND / HELLO™ Bloomington
BEYOND / HELLO™ Bloomington to Begin Serving Adult-Use Cannabis Consumers on Jan. 26, 2021BOCA RATON, Fla., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced it
Friday, January 22, 2021
Zealand Pharma announces update to 2020 financial guidance
Company announcement – No. 1 / 2021 Net operating expenses in 2020 are expected to be above the previously guided range of DKK 950-1,000 million by approximately 5-10%. Copenhagen, January 22, 2021 – with reference to the company announcement dated 12 November 2020 (interim report for the
Friday, January 22, 2021
Coherus BioSciences Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective January 21, 2021, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of
Friday, January 22, 2021
Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
CAMBRIDGE, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced closing of its previously announced underwritten public
Friday, January 22, 2021
Algernon Pharmaceuticals Provides Final Summary on Accelerated Warrants
VANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to provide a final summary of the common share purchase
Friday, January 22, 2021
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
Initial agreement provides up to 40 million doses to COVAX in 2021First deliveries are expected to take place in Q1 2021 subject to the execution of supply agreements under the COVAX Facility structureFor the COVAX Advanced Market Commitment 92 countries, Pfizer and BioNTech will provide the
Friday, January 22, 2021
Revive Therapeutics Included in First Psychedelic Exchange Traded Fund
TORONTO, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of
Friday, January 22, 2021
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2020 Financial Results Conference Call
WOBURN, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. The Company will host a conference call at 8:00 a.m., Eastern Time
Friday, January 22, 2021
Allarity Therapeutics issues new shares to Aalto Capital in connection with services rendered
Press release Hørsholm, Denmark (22 January 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announces the issue of 516,262 new shares to Aalto Capital in connection with services rendered as part of capital advisory agreement. The Company has, based
Friday, January 22, 2021
Cambium Networks Corporation Announces Fourth Quarter and Full Year 2020 Reporting Date
ROLLING MEADOWS, Ill., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium Networks”) (NASDAQ: CMBM), a leading provider of wireless networking infrastructure solutions, today announced that it plans to report financial results for the fourth quarter and full year 2020
Friday, January 22, 2021
Access-Power & Co., Inc. is pleased to announce the Company has a signed ATTORNEY AGREEMENT in place
GRAND HAVEN, Mich., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Access-Power & Co., Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company is pleased to announce after an exhaustive search, we have a signed ATTORNEY AGREEMENT in place. Patrick J Jensen, our sole Director
Friday, January 22, 2021
Bioasis Announces Stock Option Grant
GUILFORD, Conn., Jan. 22, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the
Friday, January 22, 2021
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule
BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance
Friday, January 22, 2021
Albireo Recognizes International Alagille Syndrome Awareness Day 2021
Albireo supports the Alagille syndrome community to advocate for more education and new treatment advances for rare cholestatic liver diseasesBOSTON, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid
Friday, January 22, 2021
OrthoPediatrics Corp. Introduces Orthex in Australia
WARSAW, Ind., Jan. 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, continues to expand their product offering in Australia and New Zealand. Within the past 12 months we have
Friday, January 22, 2021
